Pérdida de derivados sanguíneos: Recomendaciones medicoquirúrgicas para disminuir su uso

Autores:
Jiménez Jiménez, Cesar Eduardo
Tipo de recurso:
Article of journal
Fecha de publicación:
2005
Institución:
Fundación Universitaria de Ciencias de la Salud - FUCS
Repositorio:
Repositorio Digital Institucional ReDi
Idioma:
spa
OAI Identifier:
oai:repositorio.fucsalud.edu.co:001/2297
Acceso en línea:
https://repositorio.fucsalud.edu.co/handle/001/2297
https://doi.org/10.31260/RepertMedCir.v14.n3.2005.392
Palabra clave:
Testigos de Jehová
eritropoyetina
salvador de células
transfusión
desmopresina
Jehovah's Witnesses
erythropoietin
cell saver
transfusion
desmopressin
Rights
openAccess
License
Fundación Universitaria de Ciencias de la Salud FUCS - 0
id FUCS2_4efe1c7311f4435451ba019a229ec4ec
oai_identifier_str oai:repositorio.fucsalud.edu.co:001/2297
network_acronym_str FUCS2
network_name_str Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv Pérdida de derivados sanguíneos: Recomendaciones medicoquirúrgicas para disminuir su uso
dc.title.translated.eng.fl_str_mv Loss of blood derivatives: Medical-surgical recommendations to reduce their use
title Pérdida de derivados sanguíneos: Recomendaciones medicoquirúrgicas para disminuir su uso
spellingShingle Pérdida de derivados sanguíneos: Recomendaciones medicoquirúrgicas para disminuir su uso
Testigos de Jehová
eritropoyetina
salvador de células
transfusión
desmopresina
Jehovah's Witnesses
erythropoietin
cell saver
transfusion
desmopressin
title_short Pérdida de derivados sanguíneos: Recomendaciones medicoquirúrgicas para disminuir su uso
title_full Pérdida de derivados sanguíneos: Recomendaciones medicoquirúrgicas para disminuir su uso
title_fullStr Pérdida de derivados sanguíneos: Recomendaciones medicoquirúrgicas para disminuir su uso
title_full_unstemmed Pérdida de derivados sanguíneos: Recomendaciones medicoquirúrgicas para disminuir su uso
title_sort Pérdida de derivados sanguíneos: Recomendaciones medicoquirúrgicas para disminuir su uso
dc.creator.fl_str_mv Jiménez Jiménez, Cesar Eduardo
dc.contributor.author.spa.fl_str_mv Jiménez Jiménez, Cesar Eduardo
dc.subject.spa.fl_str_mv Testigos de Jehová
eritropoyetina
salvador de células
transfusión
desmopresina
topic Testigos de Jehová
eritropoyetina
salvador de células
transfusión
desmopresina
Jehovah's Witnesses
erythropoietin
cell saver
transfusion
desmopressin
dc.subject.eng.fl_str_mv Jehovah's Witnesses
erythropoietin
cell saver
transfusion
desmopressin
publishDate 2005
dc.date.accessioned.none.fl_str_mv 2005-09-01 00:00:00
2022-02-21T20:36:05Z
dc.date.issued.none.fl_str_mv 2005-09-01
dc.date.available.none.fl_str_mv 2005-09-01 00:00:00
2022-02-21T20:36:05Z
dc.type.spa.fl_str_mv Artículo de revista
dc.type.eng.fl_str_mv Journal article
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv Text
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv 10.31260/RepertMedCir.v14.n3.2005.392
dc.identifier.issn.none.fl_str_mv 0121-7372
dc.identifier.uri.none.fl_str_mv https://repositorio.fucsalud.edu.co/handle/001/2297
dc.identifier.eissn.none.fl_str_mv 2462-991X
dc.identifier.url.none.fl_str_mv https://doi.org/10.31260/RepertMedCir.v14.n3.2005.392
identifier_str_mv 10.31260/RepertMedCir.v14.n3.2005.392
0121-7372
2462-991X
url https://repositorio.fucsalud.edu.co/handle/001/2297
https://doi.org/10.31260/RepertMedCir.v14.n3.2005.392
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv Blood conservation and Transfusión alternatives 28th Congress of the International Society of Hematology, 2000 aug 26; Toronto, Canadá. P 5-48
Linder van der P. Perioperative blood conservation strategies: an update for clinicians. Can J of Anaesth 2003;.50 (6)
Code of practice for the surgical management oj jehovah's witnesses. London: Council of the Royal College of Surgeons of England, 2000. p 1-19; 35-43
The New York Center for Bloodless Medicine and sugery, guide. 2003, Br. J. Surg 1998; 75 (4): 44-48.
Glenn P. ¿Cómo puede salvarle la vida la sangre? 1990 watch Tower Bible and tract Society Pensilvania. Atalaya 1990; 23-7
Man M, Votto J, Kambe J. Managaement of the severely anemic patient who refuses transfusion: lessons learned during the care of a Jehovah's witness. Ann Intern Med 1992; 117: 1042-48.
Sagrada Biblia, XXXIX Congreso Eucarístico Internacional de Bogota, 1968.
Dixon L. Los testigos de Jehová el desafio quirúrgico JAMA 1981, nov; 246: 2471-72.
Dixon L. Transfusiones de sangre: ¿De quien es la decisión? ¿La conciencia de quien debe respetarse? J Med 1988; 88: 463-4.
Guzman MF, Morales de MC, Franco E. De la Responsabilidad Civil Médica. Bogotá: Ediciones Rosarista, 1995.
Cortes A. Alternativas farmacológicas a las transfusiones de sangre y componentes. Col Médica 1994;25:73-82.
Niels Q. Stten B. Birgit W. Carnsten P. Recombinant Human Erythropoietin and Hemoglobin Concentration at Operatio and during the postoperative period: Reduced need for blood transfusions in patients undergoing colorectal surgery- Prospective Double - blind placebo - controlled study. World J Sury 1999; 23: 30-5.
Rutherford C, Schneider T, Hilton D, David K. Efficacy of different regimens for recombinant human Erythropoietin in a simulated perisurgical setting: The importance of Iron availability in optimizing response. American J Med 1994; 96
Alexander K. Gombotz H. Gootfried F. Subcutaneous Recombinant Human Erythropoietin and autologous blood donation before coronary artery Bypass surgery. Anesthesia Analg 1993; 76: 102-6.
Adamson J. Spivak J. Physiologic basis for the pharmacologic use of reombinant human erythropoietin in surgery and cancer treatment. Surgery; Jan1994.
Guidelines Consensus Conference: Blood Management Surgical Practice Am J Surg; 1995: 170 (6A).
Ramos H, Satoru T, Yoog000 K. Evangelos F Howard D. Liver transplantation withouth the use of blood products. Arch Surg 1994; 129:528-533.
Cardemil G, Rodríguez M, Reyes D. Resultados del programa de atención medico-quirúrgica sin uso de sangre no hemoderivados del Hospital Clínico de la Universidad de Chile. Rev Chilena Cirugía 2004; 56 (3): 232-36.
Maclntyre A. Blood transfusion and hemostatic management in the perioperative period. Can J Anaesth 1992; 39 (5): Pt 2 R 101-14.
Fugh-Bermann A. Herb Drug interactions. Lancet 2002; 355 (9198): 134-38.
Faris P. Spende K, Larholt M.O. The predicitive power of baseline hemoglobinfor transfusion risk in surgeey patients. Orthopedics 1999:22 (1) Suppl S 135-40
Torzilli G, Makuuchi K. Inoue E. No mortality liver resection for hepatocelular carcinoma in cirrhotic and noncirrhotic patients; in there a way? A prospective analysis of our approach. Arch Surg 1999; 134 (9): 984-9.
Sabiston D,C. Principies of operative surgery: antisepsis, technique sutures and drains; Textbook of surgery ; the Biological Basis of Modem Surgical Practice, 15 th ed. Philadelphia. Saunders , 1997. pp. 253-63.
Amours D. Joshipura M, Introduction : Damage control at the start of 21st century. Sugrue M. Injury 2004; 35: suppl 639-41.
B,Cherqui R. Safety of selective vascular clamping for major hepatectomies. Malasagne. 1998; 187 (5): 482-86.
Schneeberger A, Schulz R. Blood loss in total hip arthroplasty. Lateral position combined with preservation of the capsule versus supine position combined with capsulectomy: Arch Orthop, Trauma Surg 1998; 117 (1-2): 47-9.
Postsplenectomy blood salvage in anemic patient; De Rai P.; Rebulla H.; JAMA, 258, N. 10 (1987),1332.
Evaluation of autologous she blood for autotransfusion alter orthopaedic surgery; Healy W.; Pfeifer S.; Kurtz U.; Clin. Orthop., N. 299 (1994), 53-59.
Conservation of blood during cardiovascular surgery, Cooley D.A; American Journal of Surgery , 170 , N. 6A, Suppl. (1995), 53S-59S.
Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion ;Lentschesner C.; Cottin H., Anesth. Analg. 89, N. 3, (1999), 590-597.
Central venous pressure and its effect on blood loss during liver resection ; Jones R.; Moulton M.; Br. J. Surg. 85 N. 8 (1998), 1058-1060.
Pharmacologic drugs for controlled hypotension; Testa L.D.; Tobias F.; j. Clin. Anesth.,7, N. 4 (1995),326-337.
Scott N. B. Regional anaesthesia and surgical morbidity. Br, J, Surg 1099; 75 (4): 44-p.
Grass J. Surgical outcome: regional anesthesia and analgesia versus general anaesthesia. Anesthesiol 1993; 20 (4): 117- 125.
Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction; J. Am. Coll. Surg 187, N. 6 (1998);620-625
Deliberate hypotensive anesthesia with labetalolin reconstructive surgery for scoliosis, Acta Anaesthesiol Sin, 34 N. 4; (1996); 203-207.
The role of desmopressin in reducing blood loss during lumbar fusions; Johnson R.; Murphy U.; Surg. Gynecol. Obstet.; 171, n. 3 (1990), 106-110.
Prevention of bleeding after cardiopulmonary bypass with high - dose tranexamic acid; Karski Y.; Teasdale R., J. Thorac. Cardiovasc. Surg. ,110, N.3, (1995), 835-42.
Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass surgery : a double blind randomized palcebo controlled trial; Brown G.; Thwaites R.; Anesth. Analg. 85; n.5 (1997), 963-70.
Increased safety in the administration of aprotinin , need for a test dose; Llau V.; García- Pérez M., Nesth. Analg. 90, N. 3 (2000) , 770-71.
Kesten S.A. Hoyas de C. Chaparrto I. Aprtinin reduced blood loss in lung transplant recipiente Ann Thorac, Surg 1995; 59 (4): 877-879.
Lentschesner C, Cottin H. Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion Anesth Analg 1999; 89 (3): 590-97.
aprotinin and transfusion requirements in orthoptic liver transplantation : a multicentric randomised double blind trial ; Porte Y., Moleenar T., Begliomini U ; Lancet, 335, N. 9212; (2000), 1303-1309.
Jaramillo M. Medicina Transfusional, Principios y practica medico quirúrgica. Bogotá: Proyecto Aventis, 2003.
Szalay D, Wong T, Lindsay T. Impact of red cell salvage on transfusión requirements during elective abdominal aortic aneurysm repair Ann. Vasc Surg 1999; 13 (6): 576-81.
Goodnough L. Monk G. Sicard H, J. Intraoperative salvage in patients undergoing elective abdominal aortic aneurysm reapir: an análisis of costs and benefits . J. Vasc. Surg 1996; 24 (2): 213-18.
Assesment of the availability of intraoperative autotransfusion in urological operations. J Urol 1997; 157 (5): 1777-80.
Heiss M, Anwar T. Delanoff C, Algayer H. Perisurgical erythropoietin application in anemic patients with colorectal cancer : A double - blind randomized study. Surgery 1996; my.
dc.relation.bitstream.none.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/392/444
dc.relation.citationedition.spa.fl_str_mv Núm. 3 , Año 2005 : Julio – Septiembre
dc.relation.citationendpage.none.fl_str_mv 129
dc.relation.citationissue.spa.fl_str_mv 3
dc.relation.citationstartpage.none.fl_str_mv 118
dc.relation.citationvolume.spa.fl_str_mv 14
dc.relation.ispartofjournal.spa.fl_str_mv Revista Repertorio de Medicina y Cirugía
dc.rights.spa.fl_str_mv Fundación Universitaria de Ciencias de la Salud FUCS - 0
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv Fundación Universitaria de Ciencias de la Salud FUCS - 0
https://creativecommons.org/licenses/by-nc-sa/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/392
institution Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv https://repositorio.fucsalud.edu.co/bitstreams/6cac4eff-3be8-467c-b0ce-91a87e0bf8bb/download
bitstream.checksum.fl_str_mv 07ae0e3599d4baa31253c7509ae7f70c
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv redi@fucsalud.edu.co
_version_ 1814355571607863296
spelling Jiménez Jiménez, Cesar Eduardoa80ad5ee22510dea76764241408f137e3002005-09-01 00:00:002022-02-21T20:36:05Z2005-09-012005-09-01 00:00:002022-02-21T20:36:05ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludFundación Universitaria de Ciencias de la Salud FUCS - 0info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/392Testigos de Jehováeritropoyetinasalvador de célulastransfusióndesmopresinaJehovah's Witnesseserythropoietincell savertransfusiondesmopressinPérdida de derivados sanguíneos: Recomendaciones medicoquirúrgicas para disminuir su usoLoss of blood derivatives: Medical-surgical recommendations to reduce their useapplication/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.v14.n3.2005.3920121-7372https://repositorio.fucsalud.edu.co/handle/001/22972462-991Xhttps://doi.org/10.31260/RepertMedCir.v14.n3.2005.392spaBlood conservation and Transfusión alternatives 28th Congress of the International Society of Hematology, 2000 aug 26; Toronto, Canadá. P 5-48Linder van der P. Perioperative blood conservation strategies: an update for clinicians. Can J of Anaesth 2003;.50 (6)Code of practice for the surgical management oj jehovah's witnesses. London: Council of the Royal College of Surgeons of England, 2000. p 1-19; 35-43The New York Center for Bloodless Medicine and sugery, guide. 2003, Br. J. Surg 1998; 75 (4): 44-48.Glenn P. ¿Cómo puede salvarle la vida la sangre? 1990 watch Tower Bible and tract Society Pensilvania. Atalaya 1990; 23-7Man M, Votto J, Kambe J. Managaement of the severely anemic patient who refuses transfusion: lessons learned during the care of a Jehovah's witness. Ann Intern Med 1992; 117: 1042-48.Sagrada Biblia, XXXIX Congreso Eucarístico Internacional de Bogota, 1968.Dixon L. Los testigos de Jehová el desafio quirúrgico JAMA 1981, nov; 246: 2471-72.Dixon L. Transfusiones de sangre: ¿De quien es la decisión? ¿La conciencia de quien debe respetarse? J Med 1988; 88: 463-4.Guzman MF, Morales de MC, Franco E. De la Responsabilidad Civil Médica. Bogotá: Ediciones Rosarista, 1995.Cortes A. Alternativas farmacológicas a las transfusiones de sangre y componentes. Col Médica 1994;25:73-82.Niels Q. Stten B. Birgit W. Carnsten P. Recombinant Human Erythropoietin and Hemoglobin Concentration at Operatio and during the postoperative period: Reduced need for blood transfusions in patients undergoing colorectal surgery- Prospective Double - blind placebo - controlled study. World J Sury 1999; 23: 30-5.Rutherford C, Schneider T, Hilton D, David K. Efficacy of different regimens for recombinant human Erythropoietin in a simulated perisurgical setting: The importance of Iron availability in optimizing response. American J Med 1994; 96Alexander K. Gombotz H. Gootfried F. Subcutaneous Recombinant Human Erythropoietin and autologous blood donation before coronary artery Bypass surgery. Anesthesia Analg 1993; 76: 102-6.Adamson J. Spivak J. Physiologic basis for the pharmacologic use of reombinant human erythropoietin in surgery and cancer treatment. Surgery; Jan1994.Guidelines Consensus Conference: Blood Management Surgical Practice Am J Surg; 1995: 170 (6A).Ramos H, Satoru T, Yoog000 K. Evangelos F Howard D. Liver transplantation withouth the use of blood products. Arch Surg 1994; 129:528-533.Cardemil G, Rodríguez M, Reyes D. Resultados del programa de atención medico-quirúrgica sin uso de sangre no hemoderivados del Hospital Clínico de la Universidad de Chile. Rev Chilena Cirugía 2004; 56 (3): 232-36.Maclntyre A. Blood transfusion and hemostatic management in the perioperative period. Can J Anaesth 1992; 39 (5): Pt 2 R 101-14.Fugh-Bermann A. Herb Drug interactions. Lancet 2002; 355 (9198): 134-38.Faris P. Spende K, Larholt M.O. The predicitive power of baseline hemoglobinfor transfusion risk in surgeey patients. Orthopedics 1999:22 (1) Suppl S 135-40Torzilli G, Makuuchi K. Inoue E. No mortality liver resection for hepatocelular carcinoma in cirrhotic and noncirrhotic patients; in there a way? A prospective analysis of our approach. Arch Surg 1999; 134 (9): 984-9.Sabiston D,C. Principies of operative surgery: antisepsis, technique sutures and drains; Textbook of surgery ; the Biological Basis of Modem Surgical Practice, 15 th ed. Philadelphia. Saunders , 1997. pp. 253-63.Amours D. Joshipura M, Introduction : Damage control at the start of 21st century. Sugrue M. Injury 2004; 35: suppl 639-41.B,Cherqui R. Safety of selective vascular clamping for major hepatectomies. Malasagne. 1998; 187 (5): 482-86.Schneeberger A, Schulz R. Blood loss in total hip arthroplasty. Lateral position combined with preservation of the capsule versus supine position combined with capsulectomy: Arch Orthop, Trauma Surg 1998; 117 (1-2): 47-9.Postsplenectomy blood salvage in anemic patient; De Rai P.; Rebulla H.; JAMA, 258, N. 10 (1987),1332.Evaluation of autologous she blood for autotransfusion alter orthopaedic surgery; Healy W.; Pfeifer S.; Kurtz U.; Clin. Orthop., N. 299 (1994), 53-59.Conservation of blood during cardiovascular surgery, Cooley D.A; American Journal of Surgery , 170 , N. 6A, Suppl. (1995), 53S-59S.Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion ;Lentschesner C.; Cottin H., Anesth. Analg. 89, N. 3, (1999), 590-597.Central venous pressure and its effect on blood loss during liver resection ; Jones R.; Moulton M.; Br. J. Surg. 85 N. 8 (1998), 1058-1060.Pharmacologic drugs for controlled hypotension; Testa L.D.; Tobias F.; j. Clin. Anesth.,7, N. 4 (1995),326-337.Scott N. B. Regional anaesthesia and surgical morbidity. Br, J, Surg 1099; 75 (4): 44-p.Grass J. Surgical outcome: regional anesthesia and analgesia versus general anaesthesia. Anesthesiol 1993; 20 (4): 117- 125.Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction; J. Am. Coll. Surg 187, N. 6 (1998);620-625Deliberate hypotensive anesthesia with labetalolin reconstructive surgery for scoliosis, Acta Anaesthesiol Sin, 34 N. 4; (1996); 203-207.The role of desmopressin in reducing blood loss during lumbar fusions; Johnson R.; Murphy U.; Surg. Gynecol. Obstet.; 171, n. 3 (1990), 106-110.Prevention of bleeding after cardiopulmonary bypass with high - dose tranexamic acid; Karski Y.; Teasdale R., J. Thorac. Cardiovasc. Surg. ,110, N.3, (1995), 835-42.Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass surgery : a double blind randomized palcebo controlled trial; Brown G.; Thwaites R.; Anesth. Analg. 85; n.5 (1997), 963-70.Increased safety in the administration of aprotinin , need for a test dose; Llau V.; García- Pérez M., Nesth. Analg. 90, N. 3 (2000) , 770-71.Kesten S.A. Hoyas de C. Chaparrto I. Aprtinin reduced blood loss in lung transplant recipiente Ann Thorac, Surg 1995; 59 (4): 877-879.Lentschesner C, Cottin H. Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion Anesth Analg 1999; 89 (3): 590-97.aprotinin and transfusion requirements in orthoptic liver transplantation : a multicentric randomised double blind trial ; Porte Y., Moleenar T., Begliomini U ; Lancet, 335, N. 9212; (2000), 1303-1309.Jaramillo M. Medicina Transfusional, Principios y practica medico quirúrgica. Bogotá: Proyecto Aventis, 2003.Szalay D, Wong T, Lindsay T. Impact of red cell salvage on transfusión requirements during elective abdominal aortic aneurysm repair Ann. Vasc Surg 1999; 13 (6): 576-81.Goodnough L. Monk G. Sicard H, J. Intraoperative salvage in patients undergoing elective abdominal aortic aneurysm reapir: an análisis of costs and benefits . J. Vasc. Surg 1996; 24 (2): 213-18.Assesment of the availability of intraoperative autotransfusion in urological operations. J Urol 1997; 157 (5): 1777-80.Heiss M, Anwar T. Delanoff C, Algayer H. Perisurgical erythropoietin application in anemic patients with colorectal cancer : A double - blind randomized study. Surgery 1996; my.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/392/444Núm. 3 , Año 2005 : Julio – Septiembre129311814Revista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml2559https://repositorio.fucsalud.edu.co/bitstreams/6cac4eff-3be8-467c-b0ce-91a87e0bf8bb/download07ae0e3599d4baa31253c7509ae7f70cMD51001/2297oai:repositorio.fucsalud.edu.co:001/22972024-02-02 13:12:01.784https://creativecommons.org/licenses/by-nc-sa/4.0/Fundación Universitaria de Ciencias de la Salud FUCS - 0metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co

Publicaciones similares